Industry sectors such as Finance, Construction, Tertiary, Agriculture, Engineering, Retail among others introducing frequent lateral flow testing to their working environments can help to reduce spreading of the virus across multiple workplaces, reducing transmission and therefore allowing us to open up the economy.

Antoine Dreyfus, former director of Amazon devices in the EU, is now leading a lateral flow testing project in the United Kingdom, said: “Providing regular testing for our employees will allow us to identify asymptomatic cases who might not otherwise be tested. We’re able to catch the virus earlier and place those individuals in quarantine so they can recover before infecting others. We believe this programme will help save lives.”

Other industries such as steel and car manufacturing have saved tens of thousands of lost man hours per site and reported no transmission issues through adopting frequent rapid lateral flow testing. These included Bentley and Tata Steel.

The use of Rapid mass testing has prevented outbreaks of Covid-19 within the workplace, allowing the factory to remain fully functional and avoid further transmission of the virus.

Lord Bilimoria, the president of the Confederation of British Industry (CBI), said: “To truly get to grips on this stubborn virus, we must not only continue with a successful vaccine roll-out, but get more businesses testing in the workplace. Lateral flow tests in factories, shops and work sites would mean we can catch new cases quicker when there are no symptoms.”

Regular rapid mass testing will help facilitate a more significant opening of other large industries such as infrastructure engineering, rail travel, entertainment, hospitality, manufacturing, and retail, among many more. By testing staff regularly in industry with rapid results, consumers and employees can feel safe returning to these environments and employers can have greater certainty on working hours, capacity and avoid further disruption.

The UK has led the way with its “test to suppress” Moonshots programme, announced by Prime Minister Boris Johnson, including the beginning of mass testing in education with teachers and staff in secondary schools beginning self-testing during February with primary schools following shortly after. In guidance from Public Health England, school staff have been asked to use lateral flow tests twice a week to ensure they are COVID free, with other nations expected to follow as they try to identify new variants and strains of the virus so that they are able to reduce the need for future likelihood and closures in education.

The key benefit of these lateral flow antigen tests is their ability to identify asymptomatic carriers of the virus and prevent transmission at the earliest point. This has become even more vital due to the ability for the virus to mutate to become more infectious as we have seen in the UK (Kent), south Africa and Brazil.

The World Nano Foundation and pandemic experts say regular use of inexpensive mass lateral flow rapid antigen test kits is the way to beat COVID-19, its variants, and future viruses. The adoption of rapid mass testing across populations can help pinpoint cases of the virus, reducing the likelihood of transmission and allowing those in education to feel more secure when returning to busy schools and universities, as well as allowing education professionals to deliver the highest standard of teaching once again.

As vaccination quickens across the board, the next prize is to get the world’s economies moving, with mass frequent testing as the key, using the mantra ‘test to suppress’, and as an early warning system to protect against new strains and future outbreaks.

These simple-to-manufacture rapid tests have shown a thousand-fold increase in the effectiveness and accuracy of testing with this technology. The kits can produce a positive result even when there are fewer antigens to the virus in the sample – vital for finding asymptomatic individuals and ‘super-spreaders’.

In what many believe was a game changer in preventing lockdowns, in communities and workplaces lateral flow rapid test kits (LFTs) have been mobilised now for door-to-door delivery – the UK government has secured more than 400 million of these kits – for its “Test to Suppress” strategy as well as to address fears that the South African variant had broken out in areas of the country.

Many other countries, including the US, Canada, Japan, France, Hungary as well as industries including entertainment, aviation, travel and energy to name but a few are now adopting this regular rapid testing strategy.

Innova Medical – the world’s largest manufacturer of rapid lateral flow antigen tests is ramping up to 50 million a day by the spring – has also confirmed that its COVID-19 product is effective in detecting variant strains such as the British (Kent), South African, and Brazilian variants, which appear more contagious than the earlier strains.

“As these dangerous strains show signs of increased transmissibility across communities, the global effort to eliminate COVID-19 requires frequent, comprehensive and equitable testing that can detect these emerging strains,” said Daniel Elliott, President and CEO of Innova Medical Group.

Workplace and community rapid mass testing is already starting to take place to keep economies moving and the entertainment and sports industries are said to be looking at a ‘day pass’ testing approach using LFT kits, in the same way that temperature checks were made on people using restaurants and pubs between lockdowns.

World Health Organisation Special Envoy on COVID-19, David Nabarro, had already suggested this approach:

“We’ve seen it (rapid mass testing) used in many different locations, for example in trying to keep aircraft free of people who’ve got COVID or looking after major events.”

The UK Government initiative offering LFTs in workplaces, healthcare, education, and local authorities, with private companies such as Royal Mail, the DVLA and Tate & Lyle Sugars, Jaguar, Bentley, John Lewis, London Heathrow Airport, Octopus Energy and Tata Steel also adopting frequent rapid testing.

Oxford University researchers found the UK Government’s most sensitive LFTs detected 83-90% of all infectious cases of COVID-19 and, with the UK investing more than £1.5bn in these test kits so far.

Oxford’s Regius Professor of Medicine, Sir John Bell underlined the benefit of these tests removing infectious people from high-risk environments: “They’ve found 25,000 cases just in healthcare, which may have prevented tens of thousands of cases of the disease.”

Tim Peto, Professor of Medicine, Infectious Disease, Nuffield Department of Clinical Medicine, Oxford University addressed the contrasts between PCR (polymerase chain reaction) swab testing and lateral flow kits:

“PCR is very good at telling you’ve had the virus or got the virus, but it doesn’t tell you whether you are infectious or not and the other problem about the swab test is that it takes a day or two…to get the answer back. The LFT has the enormous advantage of giving you an answer in about 30 minutes.”

He said this allows immediate self-isolation and individuals can also quickly advise their contacts so, “within a few hours, a local outbreak can be detected and this can’t be done with the swab (PCR) tests” adding that LFTs “detect people with high viral loads…the very people who are infectious.”

The World Nano Foundation (WNF) promotes healthcare technology and predicts that mass testing is central to future pandemic protection.

The not-for-profit organisation’s Co-founder Paul Sheedy said: “Our research shows how healthcare diagnostics technology will shift dramatically to a more decentralised community early intervention model, against potential epidemics and pandemics.

“Our own COVIDlytics™ modelling shows that an intensive front line ‘Test to Suppress’ campaign using rapid test kits available to the individual will allow early detection and immediate isolation, reducing the need for lockdowns.

“And our simulation maps how consecutive daily tests for three days can rapidly identify and isolate infectious people. Weekly testing can then sustain a low infection rate even in a large population. “A key point previously missed by some experts is that high quality rapid lateral flow tests are not for people who already think they have COVID-19; it’s about everyone else testing frequently to check they are not infectious.